-
Thioguanine Workflows for Cancer and EV71 Studies
2026-09-15
Thioguanine supports a practical bridge between cancer-cell pharmacology, epigenetic profiling, and EV71 virus inhibition. This workflow emphasizes solvent control, dose-window design, MIR9-pathway readouts, and troubleshooting so 6-thioguanine experiments produce interpretable rather than merely descriptive results.
-
Anlotinib Hydrochloride: From Assay to Tumor Biology
2026-09-15
Anlotinib hydrochloride connects receptor-level pharmacology with anti-angiogenic phenotypes and a clinically documented rare-tumor case. This article shows how to interpret endothelial assays, pathway data, pharmacokinetics, and translational evidence without confusing assay potency with clinical efficacy.
-
4-Hydroxytamoxifen Protocol and QC Guide
2026-09-14
This guide provides a practical DMSO-based workflow for 4-Hydroxytamoxifen, an estrogen receptor modulator used in controlled receptor, cancer, and cardiac-cell studies. It is not appropriate for protocols requiring direct water- or ethanol-soluble stocks, and the available dossier does not establish a universal dose, exposure schedule, or efficacy endpoint.
-
Metoprolol Tartrate in Translational Assays
2026-09-14
Metoprolol Tartrate is a selective β1-adrenergic blocking agent for separating cardiac receptor signaling from broader sympathetic effects. This guide translates that selectivity into practical cardiovascular and hematopoietic workflows, including comparator design, dosing logic, and troubleshooting.
-
Mitoxantrone BA2039: Reliable Cell Assays
2026-09-13
This scenario-based guide explains how Mitoxantrone (SKU BA2039) can support reproducible viability, proliferation, cytotoxicity, and ABCG2-resistance experiments. It covers mechanism, DMSO preparation, assay controls, data interpretation, and practical vendor-selection criteria using product and literature evidence.
-
Lisinopril Dihydrate: Assay Logic & ACE Selectivity
2026-09-12
Lisinopril dihydrate is a long-acting ACE inhibitor for mechanistic cardiovascular and renal research. This article explains how to interpret its potency, distinguish ACE inhibition from related peptidase effects, and design more defensible hypertension, heart failure, myocardial infarction, and nephropathy assays.
-
Charge-Reversed Exosomes for Cartilage Gene Delivery
2026-09-12
Zhang and colleagues engineered cationic, cartilage-targeting exosomes that penetrated negatively charged osteoarthritic cartilage and delivered eGFP mRNA to deep-layer chondrocytes. The study provides a preclinical framework for nonviral, intra-articular mRNA delivery while highlighting the importance of reversible electrostatic interactions, tissue retention, and disease-stage selection.
-
Viscosity-Driven P-gp Chemoresistance
2026-09-11
The reference study identifies extracellular fluid viscosity as a mechanical signal that promotes doxorubicin resistance by connecting cytoskeletal remodeling, water influx, membrane tension, TRPV4–calcium signaling, YAP activation, and P-gp upregulation. Its findings provide a mechanistic framework for drug resistance research and suggest that transporter blockade should be evaluated alongside tumor-microenvironment mechanics.
-
Ibrexafungerp Against Echinocandin-Resistant Candida
2026-09-11
This study examines ibrexafungerp, also known as MK 3118 or IBX, against a large collection of clinically derived echinocandin-resistant Candida isolates. By combining EUCAST susceptibility testing, FKS hotspot genotyping, and wild-type upper-limit analysis, it shows that activity is often retained but depends on Candida species and the position of the resistance-associated mutation.
-
DAMGO for µ-Opioid Receptor Signaling
2026-09-10
DAMGO provides a selective way to activate the µ-opioid receptor across membrane, tissue, and circuit-level assays. This guide connects receptor-proximal measurements with mechanical hypersensitivity and tolerance models, while emphasizing controls, dosing logic, and troubleshooting.
-
ATRNL1 and Cell-Specific Mechanisms in Atrial Fibrillation
2026-09-10
A large-scale single-nucleus RNA-sequencing study of human left atrial tissue identifies cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation. ATRNL1 emerged as an AF-associated cardiomyocyte gene linked to intercalated-disk localization, cellular stress responses, and cardiac action-potential regulation, providing a focused hypothesis for mechanistic and therapeutic research.
-
Copper-Catalyzed Thioazafluoranthene Synthesis
2026-09-09
The reference study reports a copper-catalyzed radical cascade that converts N-tosyl-8-ethynyl-1-naphthylamines into sulfur- and nitrogen-doped fluoranthene analogues under air. Its combination of synthetic scope, scale-up evidence, and fluorescence characterization establishes a practical route to new thioazafluoranthene fluorophores while highlighting the effect of heteroatom incorporation on optical behavior.
-
EZ Cap™ Firefly Luciferase mRNA Workflows
2026-09-09
Build sensitive gene regulation, translation, viability, and delivery assays with a Cap1- and poly(A)-optimized firefly luciferase transcript. This workflow also shows how the reporter can distinguish nanoparticle uptake from productive cytosolic mRNA release in advanced delivery studies.
-
Calpain, BDNF/TrkB, and Offspring Cognition
2026-09-08
A 2025 Neuropharmacology study identifies excessive calpain activation as a mechanistic link between maternal non-obstetric surgery during pregnancy and later cognitive impairment in rat offspring. Pharmacological rescue with MDL 28170 or a TrkB agonist connected protease activity with hippocampal BDNF/TrkB signaling, synaptic structure, and behavioral outcomes.
-
5-EdU Maps Cell-Cycle Dynamics in CNS Repair
2026-09-08
5-Ethynyl-2'-deoxyuridine (5-EdU) converts DNA synthesis into a sensitive, spatially resolved readout for cell proliferation assays. This article shows how to apply the chemistry to astrocyte–microglia communication and tissue regeneration studies without confusing S-phase entry with functional repair.